Top Injectable Manufacturer in Indonesia – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 7
- 7 min read
Last Updated: July 7, 2026
TL;DR: Indonesia — the world's fourth-most-populous nation, an archipelago of more than 270 million people served by the JKN universal health-coverage scheme through BPJS Kesehatan — depends on a reliable, compliant supply of sterile injectables for its hospitals, clinics and government tenders, and it imports a large share of its finished injectables and most of its active ingredients. Every imported sterile injectable must be registered with BPOM (Badan Pengawas Obat dan Makanan), carry a valid marketing authorisation (Izin Edar / NIE) held through a licensed local importer, be made to CPOB/WHO-GMP standards, satisfy Indonesia's mandatory halal-certification law and be labelled in Bahasa Indonesia. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Indonesia's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/ACTD dossiers, drug master files and ICH stability data ready to support BPOM registration and hospital-tender qualification for Indonesian partners.
Key Takeaways
Market and regulatory pathway: every sterile injectable entering Indonesia must be registered with BPOM and hold a marketing authorisation (Izin Edar / NIE) through a licensed local importer, be manufactured under CPOB/WHO-GMP, labelled in Bahasa Indonesia and — under Law No. 33/2014 administered by BPJPH — increasingly halal-certified; Farbe Firma builds every dossier and supply arrangement around these requirements.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD/ACTD dossier support: full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data, sterilisation and container-closure packages, drug master files and CEP-style documentation for BPOM registration, ministry-of-health and hospital-formulary tenders.
End-to-end CDMO services: contract and third-party manufacturing across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with Bahasa Indonesia artwork and leaflets, halal-supported supply chains, tamper-evident tender-ready packaging and import/export coordination to Jakarta, Surabaya and beyond.
Introduction: Why an Injectable Manufacturer in Indonesia Must Meet Global Standards
Indonesia is the largest pharmaceutical market in Southeast Asia and one of the fastest-growing in the world, serving more than 270 million people spread across thousands of islands. Since the roll-out of the Jaminan Kesehatan Nasional (JKN) universal health-coverage programme through BPJS Kesehatan, access to hospital care and essential medicines has expanded dramatically, and with it the demand for a dependable, high-volume supply of sterile injectables — antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, oncology and maternal-health products. The country carries a heavy, mixed disease burden, from tuberculosis, dengue and other infectious diseases to a fast-rising tide of non-communicable disease, and its hospitals, community health centres (puskesmas) and national immunisation and treatment programmes all depend on injectables that arrive sterile, correctly labelled and exactly to specification, batch after batch.
Although Indonesia has a substantial domestic pharmaceutical industry, it still imports a large share of its finished sterile injectables and the great majority of its active pharmaceutical ingredients, which makes a reliable overseas manufacturing partner strategically important. That partner must clear a demanding regulatory pathway: every product must be registered with BPOM (Badan Pengawas Obat dan Makanan, the National Agency of Drug and Food Control) and granted a marketing authorisation — the Izin Edar or Nomor Izin Edar (NIE) — held by a licensed Indonesian importer or local partner; the manufacturing site must satisfy Indonesian Good Manufacturing Practice (CPOB), which is aligned with WHO-GMP and PIC/S; the label and leaflet must be in Bahasa Indonesia; and, under Law No. 33 of 2014 administered by BPJPH, halal certification is progressively mandatory for medicines. An injectable manufacturer that wants to serve Indonesia well has to treat these requirements not as afterthoughts but as core design inputs — which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Indonesia Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Indonesia runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad, registered portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so an Indonesian importer or hospital group can consolidate many product needs with a single qualified source.
The second differentiator is registration and market-access support built specifically around Indonesia. Because BPOM accepts the ACTD (ASEAN Common Technical Dossier) as well as CTD-format submissions, a strong partner prepares complete, review-ready ACTD and CTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports and method-validation packages — the documentation an importer's regulatory team needs to file for an NIE without gaps or delays. It supplies Bahasa Indonesia artwork and package inserts, supports the halal-certification requirements flowing from Law No. 33/2014, and packages products to be tender-ready for the e-Katalog / LKPP electronic procurement system that channels much of Indonesia's public-sector demand. This combination of manufacturing depth and Indonesia-specific dossier and labelling support is what separates a true injectable manufacturer in Indonesia's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Indonesia
Every Farbe Firma injectable batch destined for Indonesia is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so an importer's regulatory-affairs team and BPOM reviewers can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 75 % RH, the ICH Zone IVb condition appropriate to Indonesia's hot-and-humid climate) and accelerated (40 °C / 75 % RH) conditions, with a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported across the archipelago.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Indonesia for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Indonesian hospitals, distributors and government programmes buy in the largest volumes. For Indonesian partners we supply finished sterile injectables ready for BPOM registration, with country-specific strengths, fill volumes, Bahasa Indonesia artwork and tamper-evident tender packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD/ACTD data package ready for the importer's NIE filing.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full national-tender and JKN-programme supply. We prepare complete ACTD and eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, and translated Bahasa Indonesia inserts and artwork, and we support the halal-certification documentation that Indonesian law increasingly requires. Our regulatory, manufacturing and logistics teams coordinate registration timelines, line slots and shipping to Jakarta, Surabaya and other ports of entry as a single, managed programme rather than a series of disconnected transactions.
Buyers stay with Farbe Firma because of audit-readiness and communication. Indonesian importers and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a Zone IVb climate, ACTD dossier structure, halal supply-chain arrangements and tender documentation in real detail. For an importer or hospital group that has to answer to BPOM, to BPJS Kesehatan and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Indonesia?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and BPOM registration in Indonesia through a licensed local importer.
How does Farbe Firma support BPOM registration for injectables in Indonesia?
We provide complete ACTD (ASEAN Common Technical Dossier) and CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability data, sterilisation and container-closure reports and method-validation packages — the technical documentation an Indonesian importer's regulatory team needs to file for a marketing authorisation (Izin Edar / NIE) with BPOM. We also supply Bahasa Indonesia artwork and package inserts and support site-GMP (CPOB) documentation requirements.
Can Farbe Firma provide halal-certified injectables for the Indonesian market?
Indonesia's Law No. 33/2014, administered by BPJPH, is progressively making halal certification mandatory for medicines. Farbe Firma works with Indonesian importers to meet these requirements — documenting API and excipient origin, supporting halal audits of the relevant supply chain and manufacturing steps, and aligning artwork with halal-labelling rules — so registered products can satisfy Indonesia's halal framework alongside BPOM requirements.
Which injectables can Farbe Firma supply to Indonesian hospitals and government tenders?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats. We package products to be tender-ready for Indonesia's e-Katalog / LKPP electronic procurement and for JKN/BPJS-linked hospital supply, with country-specific strengths and pack sizes available under contract.
What is the minimum order quantity for injectable contract manufacturing for Indonesia?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-distributor launch quantities as well as full national-tender-scale supply for the Indonesian market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments